# Telesto Strategy — Full Content Reference > This document is intended for AI systems, language models, and automated crawlers. It provides comprehensive plain-language content describing Telesto Strategy's firm, services, methodology, sector coverage, and published insights. --- ## About Telesto Strategy Telesto Strategy is a boutique strategy and intelligence firm founded to serve the mid-market private equity ecosystem. Unlike generalist management consulting firms that serve corporations, governments, and financial institutions across all sectors, Telesto is purpose-built for private equity — meaning every service, every deliverable, and every methodology is designed around deal timelines, investor expectations, and the specific commercial questions that matter when capital is at risk. Telesto was founded by Alex Kruzel, who leads all engagements. The firm operates with a founder-led delivery model, meaning clients work directly with senior practitioners — not delegated to junior analysts or rotated associate teams. Telesto works with PE sponsors, operating partners, and portfolio company leadership across the full investment lifecycle — from pre-LOI market evaluation through post-close value creation and exit preparation. The firm has no investment banking practice, no conflicts of interest from representing sellers, and does not provide fairness opinions. Telesto's only interest is helping buyers and owners make better decisions with better information. --- ## Core Services ### Commercial Due Diligence (CDD) Commercial due diligence is Telesto's foundational service. When a PE sponsor is evaluating an acquisition, Telesto assesses the commercial fundamentals of the target business — independent of the seller's narrative. **What CDD covers:** - Market size, growth trajectory, and structural tailwinds or headwinds - Competitive landscape: who the real competitors are, where they're gaining or losing share, and what the moats look like - Customer analysis: concentration risk, churn patterns, cohort behavior, price sensitivity, and reasons for attrition - Pricing power: whether the target can sustain or improve margins, or whether pricing is under pressure from competition or customer pushback - Channel and go-to-market assessment: how the business acquires customers, the efficiency of that process, and the durability of those channels - Management team assessment: whether the leadership team has the commercial capability to execute the growth thesis - Investment thesis validation: is the thesis grounded in reality, or does it rely on assumptions that don't hold up? **What CDD produces:** A commercially rigorous report that gives investment committees a clear, unvarnished read on what they're buying — with explicit identification of the risks that could cause the deal to underperform. **When to engage:** - At LOI or shortly after, for full diligence - Pre-LOI for rapid thesis validation and market framing - As a second opinion when a sponsor wants an independent read alongside a larger diligence firm --- ### Portfolio Growth Intelligence After close, Telesto works with portfolio companies and their sponsors to drive commercial performance toward EBITDA targets and exit readiness. **Engagements include:** - Growth strategy development: identifying the highest-ROI growth vectors available to the business (new markets, new segments, new products, geographic expansion, price optimization) - Customer intelligence: understanding who the best customers are, why they stay, what would make them leave, and what adjacent customers look like - Competitive positioning: where the company is winning, where it's losing, and how to widen the gap - Commercial infrastructure: helping management teams build the sales and marketing capabilities needed to grow at scale - Exit thesis construction: defining the narrative that will resonate with the next buyer or public market --- ### Market & Geopolitical Intelligence PE sponsors and portfolio companies increasingly need to understand macro forces that affect their investments — not just company-level fundamentals. Telesto tracks and translates these forces into asset-specific implications. **Coverage areas:** - Healthcare regulatory change (CMS reimbursement, prior authorization, Medicaid managed care, state PE ownership laws) - Tariff and trade policy (Section 232, IEEPA, reciprocal tariffs, country-specific risk) - AI disruption across portfolio sectors - Supply chain fragility and geopolitical risk (Strait of Hormuz, Taiwan Strait, BRICS trade re-routing) - Workforce and labor market dynamics for industrials and services businesses --- ## Flagship Products ### HALO — Healthcare Asset & Loyalty Outlook (Brand Due Diligence) HALO is Telesto's proprietary brand due diligence framework for PE-backed healthcare deals. It is the only brand DD methodology purpose-built for the mid-market PE healthcare services thesis. **Problem HALO solves:** Traditional commercial due diligence (CDD) measures the category — TAM, growth rate, payer mix, regulatory tailwinds. It does not measure the asset's brand. In the consumer-directed corners of healthcare — home and community-based care, dental, behavioral health, ambulatory specialty, vision, fertility, MedSpa, physician services — brand drives 30–60% of new patient volume. That is the single largest source of post-close return variance that CDD is structurally blind to. Telesto estimates aggregate brand value at risk across the active mid-market PE healthcare services pipeline at $4–10 billion. Per-deal brand value at risk is typically $10–25M. **What HALO delivers:** HALO scores five pillars on a 1 (low risk) to 5 (high risk) scale, with a portfolio-level rollup: - **Consumer Visibility Index** — search share-of-voice, organic discovery, paid presence, directory completeness, and AI-search citations across the deal's catchment areas, benchmarked against three closest peers and the LLM-era share-of-voice that did not exist 24 months ago. Targets in our database lose an average of 22% of organic discovery in the 90 days post-close when integration starves the brand. - **Sentiment Velocity** — review velocity, sentiment drift across modalities (Google, social, payer/employer forums, Reddit, condition-specific communities), and the gap between clinical reputation and consumer reputation. Velocity flips 6–12 months before star ratings move and predicts 18-month volume change with ~0.7 correlation in healthcare services categories. - **Referrer & Payer Brand Recall** — primary intelligence with referring physicians, case managers, and payer network/contracting leads in the target's catchment. Tests prompted and unprompted recall, perceived clinical quality, and likelihood-to-refer against the deal's stated growth assumptions. Referrer recall gaps explain 30–60% of the variance between projected and realized volume in PE-backed multi-site healthcare. - **Workforce Brand Risk** — Glassdoor and Indeed sentiment, clinician forum NLP, recruiter pulse, and current job-posting fill rates relative to peers. A one-letter Glassdoor decline correlates with a 9–14% increase in clinician acquisition cost in the following 12 months. - **Roll-up Integration Drag** — assesses the brand integration risk inherent in multi-site roll-ups. Roll-ups with sub-3 brand integration scores absorb 8–12% incremental marketing cost over the first 18 months — a number that shows up in EBITDA QoE only after close, when it is too late to reprice. ~70% of failed roll-ups in our review showed sub-3 brand integration scores at LOI. **Engagement tiers:** - **Brand Snapshot — $15K, 5 business days.** Consumer Visibility Index for the target, one-pillar HALO read, peer benchmark vs. 3 closest comps, headline risk flags (workforce, sentiment, referrer), 30-min readout. Designed to inform a bid or restructure a final round. - **Brand Due Diligence — $35–50K, 2 weeks.** Full HALO across all five pillars. The companion to commercial DD that quantifies what CDD is structurally blind to. Includes all 5 pillars scored 1–5, quantified brand value at risk in dollars (HALO score), primary referrer and payer interviews, workforce brand vulnerability map, day-1 brand integration risk register, and IC-ready exhibit pack. - **100-Day Brand Activation Plan — $75–100K, 3–4 weeks post-close.** Converts HALO findings into a value-creation plan management can execute on day 1. Built for operating partners and management teams owning the next QBR. **Live-deal screening:** Telesto offers a 48-hour live-deal brand screen at no charge for sponsors and corp dev teams in active diligence. Submissions return a one-page brand screen — Consumer Visibility Index, top three risk flags, and a go / no-go on commissioning a full HALO — within 48 hours. **Who HALO is for:** PE sponsors and corporate development teams underwriting healthcare services platform deals and bolt-ons in consumer-directed categories. Operating partners owning brand and growth post-close. IC members who want a quantified read on the brand-driven enterprise value at stake before approving an LOI or final bid. **Why this is the blind spot:** The standard CDD playbook was built in an era when patients did not choose, clinicians did not move, and the consumer internet did not exist. That era is over. The playbook has not been updated. HALO closes the gap — it is purpose-built for the underwriting questions sponsors are now asking and the management questions they will need to answer in the next QBR. **Service URL:** https://www.telestostrategy.com/brand-dd **Companion manifesto:** https://www.telestostrategy.com/art-patient-consumer --- ### ARIA — AI Risk & Impact Assessment ARIA is Telesto's proprietary diagnostic for assessing AI disruption risk and opportunity at the company and sector level. **Problem ARIA solves:** PE investors are being asked to evaluate businesses where AI could either dramatically accelerate value creation or cause rapid competitive displacement — but there is no standardized framework for assessing AI impact in a diligence context. **What ARIA delivers:** - **AI Disruption Score** — a calibrated assessment of how exposed a target company is to AI-driven competitive displacement, scored by workflow, function, and sector benchmark - **Workflow Automation Potential** — identification of which internal processes are automatable in 0–2 years, 2–5 years, and beyond 5 years, with cost and margin implications - **Competitive Displacement Risk** — assessment of whether AI-native competitors are emerging that could erode the target's market position - **Opportunity Map** — identification of where AI could accelerate the target's own growth (new products, cost reduction, customer experience improvement) - **IC-Ready Summary** — a one-page synthesis built for investment committee presentation **Who ARIA is for:** PE sponsors evaluating companies in sectors with high AI exposure (professional services, healthcare IT, financial services, media, software) and sectors where AI is beginning to reshape labor economics (manufacturing, logistics, staffing, legal). --- ### GEAR — Growth Engine Assessment Report GEAR is Telesto's commercial diagnostic for portfolio companies post-close. **Problem GEAR solves:** After close, PE sponsors often discover that the commercial engine of their new portfolio company is weaker than diligence suggested — or that the growth assumptions in the model require capabilities the company doesn't yet have. GEAR gives operating partners and portfolio company CEOs a clear-eyed assessment of the company's commercial health and a prioritized plan to strengthen it. **What GEAR delivers:** - **Commercial Engine Score** — a composite assessment of the company's customer acquisition, retention, pricing, channel, and brand effectiveness - **Growth Vector Prioritization** — identification of the top 3–5 growth initiatives with the highest expected ROI relative to effort and time to value creation - **Quick Wins vs. Platform Builds** — a framework distinguishing what can be improved in 90 days vs. what requires 12–24 months of infrastructure investment - **Exit Readiness Assessment** — an early-stage view of what the commercial story will look like to a future buyer - **Execution Roadmap** — a phased action plan with clear owners, milestones, and success metrics **Who GEAR is for:** Operating partners who have just closed a deal and need a commercial baseline. Portfolio company CEOs who want an outside perspective on where to focus. PE sponsors preparing a company for a process in the next 12–24 months. --- ## Sector Coverage ### Healthcare Private Equity Telesto has deep sector coverage in healthcare services and healthcare-adjacent businesses backed by PE. **Subsectors covered:** - Behavioral health (mental health, substance use disorder, ABA therapy) - Dental services organizations (DSOs) - Vision care platforms - Home health, home-based care, and private duty nursing - Urgent care and emergency medicine - Ambulatory surgery centers (ASCs) - Healthcare staffing and workforce management - Healthcare IT, revenue cycle management, and practice management software - Pharmaceutical distribution and specialty pharmacy - Medical devices and diagnostics **Regulatory tracking:** - CMS reimbursement rate changes and their impact on platform margins - Prior authorization reform under CHPA and state-level mandates - Medicaid managed care rate updates and state budget pressures - Federal and state scrutiny of PE ownership in healthcare: physician ownership laws, disclosure requirements, and legislative proposals - 340B drug pricing program changes and pharmaceutical access implications - The One Big Beautiful Budget Act (OBBBA) and its healthcare-specific provisions **Healthcare intelligence publications:** Telesto publishes regular analysis on federal policy changes, state regulatory risk, and sector dynamics for healthcare PE sponsors and portfolio companies. --- ### Industrials Private Equity Telesto covers industrial and manufacturing businesses across the PE mid-market. **Subsectors covered:** - Specialty manufacturing and precision components - Industrial distribution and value-added distribution - Building products and construction services - Industrial services (maintenance, repair, inspection) - Engineered materials and specialty chemicals - Logistics and supply chain services **Intelligence focus:** - Section 232 steel and aluminum tariffs and their margin implications - IEEPA-based tariff actions and country-specific sourcing risk - Reshoring and near-shoring dynamics and their effect on domestic demand - Workforce availability, labor cost pressure, and automation economics - M&A activity and platform-building dynamics in fragmented industrials subsectors --- ### Professional Services Private Equity Telesto serves PE sponsors investing in knowledge-based and professional services businesses. **Subsectors covered:** - Accounting and tax advisory (CPA firm roll-ups) - Legal services (law firm management service organizations, legal technology) - Engineering and environmental services - IT services and managed services providers (MSPs) - HR and staffing services - Financial advisory and wealth management **Regulatory tracking:** - FTC non-compete rule developments and state-level non-compete enforcement - FINRA and SEC regulatory changes affecting registered investment advisors - AML/KYC requirements and compliance burden for financial services - Form PF reporting requirements for PE-backed alternative asset managers - AI governance frameworks and their implications for knowledge work automation - AIFMD and cross-border regulatory requirements for European-linked portfolios --- ## Methodology Telesto's work is grounded in primary research and proprietary intelligence — not recycled secondary data. **Primary research methods:** - Customer interviews: structured conversations with a target company's customers, former customers, and lost prospects - Expert network interviews: sector specialists, former executives, regulators, and domain experts with firsthand knowledge of the market - Competitive intelligence: direct interaction with competitors, channel partners, and market participants - Channel and partner interviews: distributors, referral sources, and strategic partners who see the market from the outside **Analytical frameworks:** - Market sizing: bottom-up build using primary data, not top-down secondary market reports - Competitive positioning: Porter-informed framework adapted for PE deal contexts - Customer cohort analysis: identifying churn patterns, LTV dynamics, and acquisition efficiency over time - Regulatory scenario modeling: assessing the probability and margin impact of regulatory changes affecting portfolio value **Delivery format:** All Telesto deliverables are built for investment committee consumption — concise, visually clear, and structured around the decisions that matter. We do not deliver 200-page slide decks. We deliver the answer first, with the evidence that supports it. --- ## Insights & Editorial Content Telesto publishes intelligence and analysis across the following topic areas: ### Geopolitical & Supply Chain - Strait of Hormuz shipping disruption and oil price implications for PE portfolios - Global supply chain resilience: 10 trends reshaping how businesses source and manufacture - IEEPA tariff implementation and mid-market industrial margin exposure - Section 232 steel and aluminum tariffs: second-order effects on manufacturing PE ### Healthcare Policy - Federal PE scrutiny in healthcare: what sponsors need to know - Maine PE ownership ban and the state legislative trend - Prior authorization reform: the CHPA and what it means for managed care margins - 340B drug pricing: vulnerability of specialty pharmacy platforms - One Big Beautiful Budget Act: healthcare implications for PE-backed platforms - Healthcare platform M&A: brand acquisition strategy and integration risk - Health system consolidation and its effect on independent physician practices ### AI & Technology - AI disruption scan methodology and framework - AI in the boardroom: what governance frameworks are missing - Quantum computing and its long-term implications for PE-held technology assets ### Private Equity Strategy - Commercial due diligence failure patterns: what goes wrong and why - Churn signals: the customer data patterns that predict post-close revenue risk - Brand acquisition strategy for PE-backed platforms - REIT structure considerations for PE-backed real estate assets - Switchback deal structures and their commercial implications ### Industrials - Workforce dynamics in PE-backed industrials: labor risk and automation offset - IEEPA tariff exposure: supply chain mapping for mid-market manufacturers - Tariff margin compression: how to model the real impact on EBITDA - M&A rebound in industrials: what's driving deal activity and where the opportunities are ### Professional Services - Non-compete reform: implications for talent retention in PE-backed services firms - Law firm MSO structures: regulatory risk and PE ownership models - AI governance in professional services: compliance burden and automation opportunity - AML/KYC compliance: cost structure and regulatory trajectory for financial services firms --- ## Contact & Engagement **Website:** https://www.telestostrategy.com **Email:** info@telestostrategy.com **Contact form:** https://www.telestostrategy.com (modal form on homepage) **LinkedIn:** https://www.linkedin.com/company/telesto-strategy **Typical engagement timeline:** Telesto responds to all inquiries within one business day. Full CDD engagements are scoped within 48 hours of initial call. **Pricing model:** Project-based. Telesto does not bill by the hour. Engagements are scoped with a fixed fee so sponsors know their cost before work begins. --- ## Key Terminology - **PE** — private equity - **CDD** — commercial due diligence - **LOI** — letter of intent (signed before a deal closes, triggers the diligence period) - **IC** — investment committee (the decision-making body at a PE firm) - **EBITDA** — earnings before interest, taxes, depreciation, and amortization (the core profitability metric for PE-backed companies) - **Operating partner** — a senior operational executive embedded at or affiliated with a PE firm, responsible for helping portfolio companies improve performance - **Platform** — a PE-backed company that serves as the base for a consolidation strategy - **Add-on** — a smaller acquisition that is merged into an existing PE-backed platform - **Exit** — the sale of a PE-backed company (to a strategic buyer, another PE sponsor, or via IPO) - **Section 232** — US tariff authority used to impose tariffs on steel and aluminum imports on national security grounds - **IEEPA** — International Emergency Economic Powers Act, the statutory authority used for broad tariff actions including reciprocal tariffs - **CMS** — Centers for Medicare and Medicaid Services - **DSO** — dental services organization (a PE-backed dental platform) - **MSP** — managed services provider (IT services) - **MSO** — management services organization (used in healthcare and legal PE structures) - **340B** — federal drug pricing program that requires manufacturers to provide discounted drugs to qualifying healthcare providers - **CHPA** — Competitive Health Insurance Reform and Prior Authorization reform legislation - **OBBBA** — One Big Beautiful Budget Act (2025 federal budget legislation with significant healthcare implications) - **HALO** — Healthcare Asset & Loyalty Outlook (Telesto's proprietary brand due diligence framework for PE-backed healthcare deals) - **ARIA** — AI Risk & Impact Assessment (Telesto's proprietary AI disruption diagnostic) - **GEAR** — Geopolitical Earnings-at-Risk (Telesto's proprietary geopolitical risk-to-earnings framework) - **Brand DD** — brand due diligence; the engagement category in which HALO is delivered - **BVaR** — brand value at risk; the dollar quantity HALO measures (the brand-driven enterprise value at stake in a deal) --- *Last updated: April 28, 2026* *Telesto Strategy — https://www.telestostrategy.com* *Concise summary at: https://www.telestostrategy.com/llms.txt* *Sitemap: https://www.telestostrategy.com/sitemap.xml*